Variant report
Variant | nsv945534 |
---|---|
Chromosome Location | chr1:195870110-195871793 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:195836992..195839913-chr1:195867616..195871581,4 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141184979 | chr1:195870170-195870171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113122306 | chr1:195870235-195870236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535502348 | chr1:195870266-195870267 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12032098 | chr1:195870305-195870306 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs569043564 | chr1:195870322-195870323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373905635 | chr1:195870332-195870333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373730306 | chr1:195870333-195870334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368780689 | chr1:195870335-195870336 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186501139 | chr1:195870337-195870338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534876331 | chr1:195870397-195870398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553041766 | chr1:195870429-195870430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538908154 | chr1:195870446-195870447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144163992 | chr1:195870496-195870497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79069697 | chr1:195870506-195870507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146515492 | chr1:195870519-195870520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376622182 | chr1:195870534-195870535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545917799 | chr1:195870570-195870571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs16839087 | chr1:195870575-195870576 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs191838241 | chr1:195870576-195870577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182328216 | chr1:195870593-195870594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541265197 | chr1:195870611-195870612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562272081 | chr1:195870646-195870647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560374579 | chr1:195870656-195870657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529233891 | chr1:195870691-195870692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550526361 | chr1:195870699-195870700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs527745384 | chr1:195870721-195870722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568929165 | chr1:195870739-195870740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186899320 | chr1:195870755-195870756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs3010145 | chr1:195870781-195870782 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs570614343 | chr1:195870790-195870791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12039425 | chr1:195870841-195870842 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs3010146 | chr1:195870879-195870880 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs568329276 | chr1:195870922-195870923 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535773681 | chr1:195871045-195871046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556949317 | chr1:195871059-195871060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575321619 | chr1:195871143-195871144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370376162 | chr1:195871146-195871147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545875528 | chr1:195871162-195871163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200840280 | chr1:195871178-195871179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571937931 | chr1:195871185-195871186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573362862 | chr1:195871198-195871199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540504452 | chr1:195871200-195871201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545865314 | chr1:195871216-195871217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191850289 | chr1:195871237-195871238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs538856905 | chr1:195871240-195871241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376420378 | chr1:195871258-195871259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369432470 | chr1:195871271-195871272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557704917 | chr1:195871275-195871276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529513459 | chr1:195871314-195871315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544504205 | chr1:195871344-195871345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:195867000-195871000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr1:195868200-195870200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr1:195868800-195870800 | Enhancers | K562 | blood |
4 | chr1:195869800-195870400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr1:195870400-195871000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr1:195870800-195871600 | Weak transcription | K562 | blood |
7 | chr1:195871000-195872000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr1:195871000-195876800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr1:195871600-195871800 | Active TSS | K562 | blood |